AGP Executive Report
Last update: 4 hours agoHeart Health: Hengrui Pharma and Braveheart Bio reported 52-week results for their investigational treatment for obstructive hypertrophic cardiomyopathy, with improvements in exercise capacity and patient-reported outcomes. Workplace Wellness: Sands China’s Occupational Safety and Health Month is offering staff flu vaccinations, chronic disease screenings, healthy-eating activities and workshops, alongside a new health ambassador programme. Health and Longevity: A summit at Studio City brought more than 360 guests and 25 speakers together to discuss health, longevity and medical tourism in the Greater Bay Area. Postnatal Care: A Macau survey found 62.7% of respondents want stronger postnatal physical recovery services, while 68.4% called for more childcare training and confinement support. Hospital Services: Macao Union Hospital has launched iodine-131 services, expanding local access to this form of care.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
